The value of white matter hyperintensity lesions in patients with antiphospholipid syndrome and systemic Lupus erythematosus

被引：0
|
作者：
Sanna, G.
Gordon, P.
Almeida, A.
Bertolaccini, M. L.
Hughes, G. R. V.
Hunt, B.
Khamashta, M. A.
机构：
[1] Homerton Univ Hosp NHS Fdn Trust, Dept Rheumatol, London, England
[2] Kings Coll Hosp London, Dept Rheumatol, London, England
[3] Guys & St Thomas NHS Fdn, Dept Hematol, London, England
[4] Kings Coll London, Sch Med, St Thomas Hosp, Lupus Res Unit,Rayne Inst, London WC2R 2LS, England
来源：
RHEUMATOLOGY | 2006年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I159 / I160
页数：2
相关论文
共 50 条
  • [21] The value of IgA antiphospholipid testing for the diagnosis of antiphospholipid syndrome in systemic lupus erythematosus.
    Bertolaccini, ML
    Atsumi, T
    Escudero, A
    Khamashta, MA
    Hughes, GRV
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S147 - S147
  • [22] Hyperhomocysteinemia in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and antiphospholipid syndrome associated with lupus.
    Prieto, MP
    Muñoz, G
    Hernández, B
    López, LA
    Vargas, A
    González, EH
    Valdéz, MR
    Amigo, MC
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 422 - 422
  • [23] The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus
    Bertolaccini, ML
    Atsumi, T
    Contreras, AE
    Khamashta, MA
    Hughes, GRV
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (12) : 2637 - 2643
  • [24] Impact of white matter lesions on processing speed deficits in systemic lupus erythematosus patients
    Pawlak, M.
    Kalinowska-Lyszczarz, A.
    Forycka, M.
    Wilkosc, M.
    Serafin, Z.
    Pawlak-Bus, K.
    Leszczynski, P.
    Wiesik-Szewczyk, E.
    Kazmierski, R.
    Kozubski, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 584 - 584
  • [25] COGNITIVE IMPAIRMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS
    Borisova, A.
    Lisitsyna, T.
    Veltishchev, D.
    Reshetnyak, T.
    Seravina, O.
    Kovalevskaya, O.
    Cheldieva, F.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1180 - 1180
  • [26] Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome
    Paran, Daphna
    Caspi, Dan
    Levartovsky, David
    Elkayam, Ori
    Kaufman, Ilana
    Litinsky, Irena
    Keren, Gad
    Koifman, Bella
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 506 - 510
  • [27] Antiphospholipid syndrome: Cohort of Tunisian patients with systemic lupus erythematosus
    Hammami, S.
    Chebbi, W.
    Aloui, S.
    Boumiza, R.
    Hamzaoui, A.
    Hassine, M.
    ElMay, M.
    Mahjoub, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 128 - 128
  • [28] Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
    Reshetnyak, Tatiana
    Nurbaeva, Kamila
    Ptashnik, Ivan
    Kudriaeva, Anna
    Belogurov Jr, Alexey
    Lila, Aleksandr
    Nasonov, Evgeny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
  • [29] FXIII levels in patients with systemic lupus erythematosus and antiphospholipid syndrome
    Bagoly, Z.
    Toth, N. K.
    Tarr, T.
    Soltesz, P.
    Katona, E.
    Mezei, Z. A.
    Muszbek, L.
    CLINICA CHIMICA ACTA, 2019, 493 : S416 - S417
  • [30] Inadequate Screening for Antiphospholipid Syndrome with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
    Munawar, Tooba
    Sherazi, Mahnoor
    Perl, Andras
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1810 - 1811
12345